Healthcare and Materials Firms Beat Targets as Consumer Segment Faces HeadwindsGlobal Report·2 days ago, 04:13 AMAGI-2.01%SENS-0.79%
The Biotech Survival Charade: Stop Buying the "AI Pivot" HypeGlobal Report·Jul 26 at 04:14 AMINM-2.00%ONCY+4.00%
Inside the Biotech Sector's Recent Clinical Catalyst WaveGlobal Report·Jul 25 at 04:17 AMGENB-0.21%IBRX-3.76%
Consumer Resilience Meets Sector Divergence: A Microcosm for Fed OfficialsGlobal Report·Jul 25 at 04:13 AMKR-0.21%TDC+1.41%
Oncolytics Biotech Disclosed Failure to Satisfy a Continued Listing Rule or StandardTradingView·Jul 24 at 03:43 PMONCY+4.00%
The AI Pivot Pain: Inside monday.com's Layoffs and the Broader Strategic OverhaulsGlobal Report·Jul 24 at 04:13 AMMNDY-1.15%NTNX-0.42%
Columbia Financial's USD 1.7B Raise and Timken's Guidance Hike Lead Mid-2026 Strategic ShiftsGlobal Report·Jul 22 at 04:18 AMCLBK-1.28%TKR+1.06%
Oncolytics Biotech wins FDA Fast Track status for pelareorep in second-line anal cancerPUBT·Jul 20 at 08:08 AMONCY+4.00%
The Divergence of Moats: Physical Infrastructure, Strategic Pivots, and Survival MechanicsGlobal Report·Jul 19 at 04:12 AMWU-17.30%NAK+0.72%
